|
1
|
Bacci G, Longhi A, Versari M, Mercuri M,
Briccoli A and Picci P: Prognostic factors for osteosarcoma of the
extremity treated with neoadjuvant chemotherapy: 15-year experience
in 789 patients treated at a single institution. Cancer.
106:1154–1161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferguson WS and Goorin AM: Current
treatment of osteosarcoma. Cancer Invest. 19:292–315. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Polakis P: Wnt signaling and cancer. Gene
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
5
|
Uematsu K, He B, You L, Xu Z, McCormick F
and Jablons DM: Activation of the Wnt pathway in non small cell
lung cancer: evidence of dishevelled overexpression. Oncogene.
22:7218–7221. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hatsell S, Rowlands T, Hiremath M and
Cowin P: Beta-catenin and Tcfs in mammary development and cancer. J
Mammary Gland Biol Neoplasia. 8:145–158. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang QL, Zhao ZQ, Li JC, Liang Y, Yin JQ,
Zou CY, Xie XB, Zeng YX, Shen JN and Kang T: Salinomycin inhibits
osteosarcoma by targeting its tumor stem cells. Cancer Lett.
311:113–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Patel D, Shukla S and Gupta S: Apigenin
and cancer chemo-prevention: Progress, potential and promise
(Review). Int J Oncol. 30:233–245. 2007.
|
|
9
|
Wang W, Heideman L, Chung CS, Pelling JC,
Koehler KJ and Birt DF: Cell-cycle arrest at G2/M and growth
inhibition by apigenin in human colon carcinoma cell lines. Mol
Carcinog. 28:102–110. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Way TD, Kao MC and Lin JK: Apigenin
induces apoptosis through proteasomal degradation of HER2/neu in
HER2/neuoverexpressing breast cancer cells via the
phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem.
279:4479–4489. 2004. View Article : Google Scholar
|
|
11
|
Ujiki MB, Ding X-Z, Salabat MR, Bentrem
DJ, Golkar L, Milam B, Talamonti MS, Bell RH, Iwamura T and Adrian
TE: Apigenin inhibits pancreatic cancer cell proliferation through
G2/M cell cycle arrest. Mol Cancer. 5:762006. View Article : Google Scholar
|
|
12
|
Lin CC, Chuang YJ, Yu CC, Yang JS, Lu CC,
Chiang JH, Lin JP, Tang NY, Huang AC and Chung JG: Apigenin induces
apoptosis through mitochondrial dysfunction in U-2 OS human
osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth
in vivo. J Agric Food Chem. 60:11395–11402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu X, Zhang X, Xiang J, Lv Y and Shi J:
miR-451: Potential role as tumor suppressor of human hepatoma cell
growth and invasion. Int J Oncol. 45:739–745. 2014.PubMed/NCBI
|
|
14
|
Jaffe N: Osteosarcoma: review of the past,
impact on the future. The American experience. Cancer Treat Res.
152:239–262. 2009. View Article : Google Scholar
|
|
15
|
Hu XW, Meng D and Fang J: Apigenin
inhibited migration and invasion of human ovarian cancer A2780
cells through focal adhesion kinase. Carcinogenesis. 29:2369–2376.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan K, Gao J, Yang T, Ma Q, Qiu X, Fan Q
and Ma B: MicroRNA-34a inhibits the proliferation and metastasis of
osteosarcoma cells both in vitro and in vivo. PLoS One.
7:e337782012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brabletz T, Jung A, Dag S, Hlubek F and
Kirchner T: Beta-catenin regulates the expression of the matrix
metalloproteinase-7 in human colorectal cancer. Am J Pathol.
155:1033–1038. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li YJ, Wei ZM, Meng YX and Ji XR:
Beta-catenin up-regulates the expression of cyclinD1, c-myc and
MMP-7 in human pancreatic cancer: relationships with carcinogenesis
and metastasis. World J Gastroenterol. 11:2117–2123. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pu P, Zhang Z, Kang C, Jiang R, Jia Z,
Wang G and Jiang H: Downregulation of Wnt2 and beta-catenin by
siRNA suppresses malignant glioma cell growth. Cancer Gene Ther.
16:351–361. 2009. View Article : Google Scholar
|
|
21
|
Kansara M, Tsang M, Kodjabachian L, Sims
NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons
PJ, Dawid IB and Thomas DM: Wnt inhibitory factor 1 is
epigenetically silenced in human osteosarcoma, and targeted
disruption accelerates osteosarcomagenesis in mice. J Clin Invest.
119:837–851. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kidani T, Nakamura A, Kamei S, Norimatsu
Y, Miura H and Masuno H: Overexpression of cytoplasmic β-catenin
inhibits the metastasis of the murine osteosarcoma cell line LM8.
Cancer Cell Int. 14:312014. View Article : Google Scholar
|
|
23
|
Lin CH, Ji T, Chen CF and Hoang BH: Wnt
signaling in osteosarcoma. Adv Exp Med Biol. 804:33–45. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang F, Chen A, Chen J, Yu T and Guo F:
SiRNA-mediated silencing of beta-catenin suppresses invasion and
chemosensitivity to doxorubicin in MG-63 osteosarcoma cells. Asian
Pac J Cancer Prev. 12:239–245. 2011.PubMed/NCBI
|
